Literature DB >> 3619427

Concentrations of ticarcillin and clavulanic acid in human bone after prophylactic administration of 5.2 g of timentin.

D Adam, H D Heilmann, K Weismeier.   

Abstract

The penetration of ticarcillin and clavulanate into their distribution space within human bone was determined after prophylactic administration of 5.2 g of timentin (5 g of ticarcillin plus 0.2 g of clavulanic acid) to 20 patients undergoing hip surgery. All samples were taken 45 to 85 min postadministration. The mean concentrations of ticarcillin in spongiosa and corticalis bone were 57.1 and 70.5 mg/kg, respectively; those of clavulanic acid were 17.8 and 32.5 mg/kg, respectively. No infections occurred in these patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619427      PMCID: PMC284215          DOI: 10.1128/AAC.31.6.935

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

2.  [Demonstration of trimethoprim in normal and inflamed bone tissue].

Authors:  F Klapp; G Baldauf; J S Braun; P Poeplau; P Hertel
Journal:  Med Welt       Date:  1973-06-01

3.  Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid.

Authors:  S Bennett; R Wise; D Weston; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

4.  In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin.

Authors:  P A Hunter; K Coleman; J Fisher; D Taylor
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

5.  An approach to the management of infection in bone.

Authors:  S P Hughes
Journal:  J R Coll Surg Edinb       Date:  1982-03

Review 6.  Antibiotic assays in muscle: are conventional tissue levels misleading as indicator of the antibacterial activity?

Authors:  D M Ryan; O Cars
Journal:  Scand J Infect Dis       Date:  1980

7.  Pharmacokinetics of cefamandole in osseous tissue.

Authors:  R J Lunke; R H Fitzgerald; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

8.  Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination.

Authors:  D Adam; I de Visser; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

9.  Flucloxacillin in bone.

Authors:  P F Unsworth; F W Heatley; I Phillips
Journal:  J Clin Pathol       Date:  1978-08       Impact factor: 3.411

10.  [Use of hydroxyapatite for determination of antibiotic concentrations in bone].

Authors:  D H Wittmann; D Berghoff; V Reynders-Frederix; H H Schassan
Journal:  Arzneimittelforschung       Date:  1983
View more
  6 in total

1.  Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues.

Authors:  S J Incavo; P J Ronchetti; J H Choi; H Wu; M Kinzig; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

3.  Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis.

Authors:  L Mizen; G Woodnutt; I Kernutt; E J Catherall
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

Review 4.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

5.  Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulation.

Authors:  Cornelia B Landersdorfer; Martina Kinzig; Jürgen B Bulitta; Friedrich F Hennig; Ulrike Holzgrabe; Fritz Sörgel; Johannes Gusinde
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

Review 6.  Pharmacokinetic disposition of quinolones in human body fluids and tissues.

Authors:  F Sörgel; U Jaehde; K Naber; U Stephan
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.